Mylan Shares Rise 10% After FTC Decision
From Bloomberg News
Shares of Mylan Laboratories Inc. gained 10% after billionaire financier Carl Icahn received clearance from the Federal Trade Commission to acquire as much as 12% of the largest U.S. maker of generic drugs.
The action allows Icahn to purchase $100 million to $500 million worth of Mylan shares, the company said.
Icahn did not return calls. Mylan shares rose $1.62 to $17.20 on the New York Stock Exchange.
